Exemestane may be less detrimental than letrozole to bone health in women homozygous for the UGT2B17*2 gene deletion

Document Details

Document Type
Pub Defense Publication
Publication Date
Feb 12, 2019
Source ID
10.1007/s10549-019-05158-3

Entities

People

  • Ana-maria Storniolo
  • Brandi L. Clark
  • Bryana J. Gregory
  • Christina L. Gersch
  • Daniel F. Hayes
  • Daniel L. Hertz
  • James M. Rae
  • Jingyue Xi
  • Kelley M. Kidwell
  • Landry K Kamdem
  • N. Lynn Henry
  • Vered Stearns

Organizations

  • National Institute of General Medical Sciences
  • National Institutes of Health
  • Pfizer (Canada)
  • United States Department of Defense